|
Real-time Estimate
Cboe BZX
18:28:02 19/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.915 USD | +2.75% |
|
-5.48% | -35.10% |
| 10-14 | Stifel Initiates Immatics at Buy With $15 Price Target | MT |
| 10-02 | Nanobiotix Names New Finance Chief | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMATICS N.V. | Bio Therapeutic Drugs | +1.11% | -5.48% | -35.10% | -37.82% | -48.53% | 920M |  | | |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
